These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10492622)

  • 41. [Preparation of ondansetron hydrochloride sustained-release tablet evaluation of its and drug release behavior in vitro].
    Zhang Y; Huang G; Yu Y; Han J; Yu P
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Jun; 23(3):597-600, 614. PubMed ID: 16856397
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sustained release tablets based on chitosan and carboxymethylcellulose sodium.
    Inouye K; Machida Y; Nagai T
    Drug Des Deliv; 1987 May; 1(4):297-305. PubMed ID: 3509339
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Application of guar gum biopolymer in the prescription of tablets with sodium ibuprofen--quality tests and pharmaceutical availability in vitro.
    Berner-Strzelczyk A; Kołodziejska J; Zgoda MM
    Polim Med; 2006; 36(4):3-11. PubMed ID: 17402228
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Two release rates from monolithic carboxymethyl starch tablets: formulation, characterization, and in vitro/in vivo evaluation.
    Le TC; Mateescu MA
    Drug Deliv Transl Res; 2017 Aug; 7(4):516-528. PubMed ID: 28386870
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Usage of chitosan as a pharmaceutical material effectiveness as an additional additives of sodium alginate].
    Miyazaki T; Komuro T; Yomota C; Okada S
    Eisei Shikenjo Hokoku; 1990; (108):95-7. PubMed ID: 1364368
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Influence of different sources on the processing and biopharmaceutical properties of high-dose ibuprofen formulations.
    Romero AJ; Lukas G; Rhodes CT
    Pharm Acta Helv; 1991; 66(2):34-43. PubMed ID: 1758891
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Buoyant sustained release granules based on chitosan: comments on the article by Inouye et al.
    Touitou E
    Drug Des Deliv; 1989 Dec; 5(2):167. PubMed ID: 2577987
    [No Abstract]   [Full Text] [Related]  

  • 48. Comparison of the hematological effects of a sustained release chitosan formulation of pentoxifylline with a commercial formulation.
    Yamac K; Kaptan KM; Beyan C; Teksin ZS; Ağabeyoğlu IT; Gökgöz L
    Arzneimittelforschung; 2000 Sep; 50(9):827-31. PubMed ID: 11050700
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vitro aceclofenac release from IPN matrix tablets composed of chitosan-tamarind seed polysaccharide.
    Jana S; Sen KK; Basu SK
    Int J Biol Macromol; 2014 Apr; 65():241-5. PubMed ID: 24463265
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Drug release from lipid matrices. Part II. Influence of formulation factors on the release of slightly soluble drug.
    Ozdemir N; Ozates B
    Acta Pol Pharm; 1996; 53(2):107-10. PubMed ID: 8960285
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Quality tests for ibuprofen preparations].
    Miyazaki T; Yomota C; Okada S; Komuro T
    Eisei Shikenjo Hokoku; 1992; (110):122-4. PubMed ID: 1364422
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ibuprofen-loaded chitosan and chemically modified chitosans--release features from tablet and film forms.
    Vieira AP; Badshah S; Airoldi C
    Int J Biol Macromol; 2013 Jan; 52():107-15. PubMed ID: 23010457
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tableting of coated particles. I. Small particle size chitosan as an agent protecting coating membrane from mechanical damage of compression force.
    Yao T; Yamada M; Yamahara H; Yoshida M
    Chem Pharm Bull (Tokyo); 1997 Sep; 45(9):1510-4. PubMed ID: 9332004
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of in vitro dissolution profile comparison methods of sustained release tramadol hydrochloride liquisolid compact formulations with marketed sustained release tablets.
    Karmarkar AB; Gonjari ID; Hosmani AH; Dhabale PN
    Drug Discov Ther; 2010 Feb; 4(1):26-32. PubMed ID: 22491149
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mechanistic modeling of drug release from chitosan coated tablets.
    Koizumi T; Ritthidej GC; Phaechamud T
    J Control Release; 2001 Feb; 70(3):277-84. PubMed ID: 11182198
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of low-molecular casein and gelatin on absorption of ibuprofen after oral and rectal administration.
    Kimura S; Imai T; Otagiri M
    Pharm Acta Helv; 1991; 66(4):120-4. PubMed ID: 1758897
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Biodegradable chitosan matrix for the controlled release of steroids.
    Chandy T; Sharma CP
    Biomater Artif Cells Immobilization Biotechnol; 1991; 19(4):745-60. PubMed ID: 1810408
    [TBL] [Abstract][Full Text] [Related]  

  • 58. N-acylated chitosan: hydrophobic matrices for controlled drug release.
    Le Tien C; Lacroix M; Ispas-Szabo P; Mateescu MA
    J Control Release; 2003 Nov; 93(1):1-13. PubMed ID: 14602417
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sustained release of indomethacin from chitosan granules in beagle dogs.
    Miyazaki S; Yamaguchi H; Yokouchi C; Takada M; Hou WM
    J Pharm Pharmacol; 1988 Sep; 40(9):642-3. PubMed ID: 2907032
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vivo evaluation of matrix granules containing microcrystalline chitosan as a gel-forming excipient.
    Säkkinen M; Linna A; Ojala S; Jürjenson H; Veski P; Marvola M
    Int J Pharm; 2003 Jan; 250(1):227-37. PubMed ID: 12480288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.